BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11431191)

  • 21. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal fluid and solute transport with different polyglucose formulations.
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Perit Dial Int; 1998; 18(2):193-203. PubMed ID: 9576369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR; Zweers MM; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the preceding exchange on peritoneal equilibration test results.
    Figueiredo AE; Conti A; Poli de Figueiredo CE
    Adv Perit Dial; 2002; 18():75-7. PubMed ID: 12402592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume-Based Peritoneal Dialysis Prescription Guide to Achieve Adequacy Targets.
    Akonur A; Firanek CA; Gellens ME; Hutchcraft AM; Kathuria P; Sloand JA
    Perit Dial Int; 2016; 36(2):188-95. PubMed ID: 26293841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
    Akonur A; Guest S; Sloand JA; Leypoldt JK
    Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peritoneal equilibrium test using icodextrin and glucose at different concentrations].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Gallego T; Delgado-Pecellín C; Benítez M; Torán CD
    Nefrologia; 2002; 22(4):340-7. PubMed ID: 12369125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
    Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
    Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis.
    Piraino B; Bender F; Bernardini J
    Perit Dial Int; 1994; 14(2):145-8. PubMed ID: 8043667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.
    Vonesh EF; Story KO; O'Neill WT
    Perit Dial Int; 1999; 19(6):556-71. PubMed ID: 10641777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal equilibration test performed in predialysis patients.
    Petersen LJ; Nielsen AL
    Int J Artif Organs; 1995 Jan; 18(1):3-5. PubMed ID: 7607755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children.
    Schaefer F; Langenbeck D; Heckert KH; Schärer K; Mehls O
    Adv Perit Dial; 1992; 8():410-5. PubMed ID: 1361835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calculation of 6-hour D/P creatinine ratio from the 4-hour peritoneal equilibration test. The effect of dwell duration on the results.
    Mehrotra R; Khanna R; Yang TC; Kathuria P; Moore HL; Prowant BF; Nolph KD; Twardowski ZJ
    Perit Dial Int; 1997; 17(3):273-8. PubMed ID: 9237289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.